BGI Precision Nutrition (Umeta)
华大营养 / 华大精准营养（深圳）科技有限公司（优美达）
BGI's (华大) precision-nutrition arm sits on one of the largest human-commensal microbial strain libraries in China — 50,000–60,000+ gut/commensal strains built on BGI's sequencing scale — and runs a full 'test → functional probiotic → nutrition' chain; it is the single biggest microbial-resource-discovery asset in the GBA and a credible strain / data / co-research partner.
- Location
- Yantian District (BGI Center) · Shenzhen
- Visit window
- From the Nanshan base · Jul 13–31
- Source status
- medium confidencecandidate
Next action
Prepare the private outreach route and meeting ask; keep contact details out of the app.
Why now: Visit window · From the Nanshan base · Jul 13–31
What they do
华大营养 (BGI Nutrition) and the 优美达 (Umeta) probiotics brand translate BGI's ~18 years of human-microbiome sequencing into products and services, running a strain-selection → functional-verification → compatibility-research pipeline over a strain library of 50,000–60,000+ human gut/commensal bacteria. The chain spans microbiome testing, functional probiotic intervention and nutrition services, with ~100 strain/health patents and clinical ties to major hospitals.
Why it matters
High on the microbial-resource-discovery axis (Pure Advance's lead priority) — arguably the deepest strain-library + microbiome-data resource in the Greater Bay Area. The attraction is access to a very large, characterised commensal strain collection plus BGI's sequencing/bioinformatics depth for high-throughput screening and functional discovery. Caveats: it is gut/nutrition-centric, and data-governance can make strain/data deals slow; treat as a flagship strain-access relationship, not a quick transaction.
Visit objective & route
Explore a strain-access / co-discovery relationship with the precision-nutrition arm — access to a large characterised commensal strain library plus BGI's sequencing/bioinformatics for microbial-resource discovery; a flagship learning + strain-access relationship, not a quick transaction.
Approach route
Warm intro (incubator network / China Gut Conference / a BGI contact) to the precision-nutrition arm — not BGI Genomics; pre-arrange a host.
Talking points
- Whether any of the 50,000+ strains are available for licensing / co-research with an external party, and on what data-governance terms.
- Confirm the right legal entity/contact for the nutrition arm (华大营养 vs 华大精准营养) and whether they take external strain-access/co-discovery partnerships.
- Whether BGI's sequencing/bioinformatics + AI could support high-throughput screening for a biocontrol/microbial-resource discovery programme.
- Whether any skin/postbiotic/topical work exists (Coolvex angle) vs purely gut/oral nutrition.
Open questions
- Exact legal entity and right contact for the nutrition/probiotic arm; whether they take external strain-access/co-discovery partnerships.
- Whether the 50,000+ strains are licensable for external co-research and on what (likely restrictive) data-governance terms.
- Whether any skin/topical or postbiotic-active work exists vs purely gut/oral nutrition.
- Current 2026 strain-library size and patent count (figures are 2023-era).
- Physical visit site: BGI Center vs a dedicated nutrition facility.
- Any GCC/halal-positioned probiotic line.
Risks & unknowns
- Huge and gut/nutrition-centric; a Coolvex skin angle is a research ask, not an off-the-shelf buy.
- Data-governance / China-data-sensitivity means strain or data deals can be slow and heavily papered.
- Engage the precision-nutrition arm, not BGI Genomics — easy to reach the wrong entity.
- Realistically only worth a visit if pre-arranged; not a walk-in.
Private-pack boundary